Influence of iodine supplementation on serum insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) levels in severe iodine deficiency

Turkish Journal of Pediatrics

Volumn 46, Issue 4, 2004, Pages 303-308

  Özön, Alev ^a   Alikaşifoǧlu, Ayfer ^a   Yordam, Nurşen ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Insulin like growth factor binding protein 3; Insulin like growth factor I; Iodine deficiency

Indexed keywords

IODINATED POPPYSEED OIL; IODINE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; THYROTROPIN; THYROXINE;

ADOLESCENT; ARTICLE; BODY HEIGHT; BRAIN INJURY; CHILD; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DISEASE SEVERITY; DRUG EFFECT; FEMALE; GROWTH DISORDER; HEARING DISORDER; HUMAN; IODINE DEFICIENCY; LEARNING DISORDER; MAJOR CLINICAL STUDY; MALE; PREPUBERTY; PROTEIN BLOOD LEVEL; PUBERTY; PUBLIC HEALTH; SCORING SYSTEM; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIETARY SUPPLEMENTS; FEMALE; GROWTH AND DEVELOPMENT; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; IODINE; MALE; SOMATOMEDINS; THYROTROPIN; THYROXINE; TREATMENT OUTCOME;

EID: 11344263347     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Arthur JR, Beckett GJ. Thyroid function. Br Med Bull 1999; 55: 658-668.
2. Alikaşifoǧlu A, Özön A, Yordam N. Serum insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 levels in severe iodine deficiency. Turk J Pediatr 2002; 44: 215-218.
3. Blum WF, Ranke MB. Use of insulin-like growth factor binding protein-3 for the evaluation of growth disorders. Horm Res 1990; 34 (Suppl): 31-37.
4. Wan Nazaimoon WM, Osman A, Wu LL, Khalid BA. Effects of iodine deficiency on insulin-like growth factor-I, insulin-like growth factor-binding protein-3 levels and height attainment in malnourished children. Clin Endocrinol 1996; 45: 79-83.
5. Sandell EB, Kolthoff M. Microdetermination of iodine by a catalytic method. Microchem Acta 1937; 1: 9-25.
6. Rolland-Cachera MF, Sempe M, Guilloud-Bataille M, Patois E, Pequignot-Guggenbuhl F, Fautrad V. Adiposity indices in children. Am J Clin Nutr 1982; 36: 178-184.
7. Tanner JM, Whitehouse RH, Takaishi M. Standards from birth to maturity for height, weight, height velocity and weight velocity of British children. Arch Dis Child 1965; 41 (Part I) 457-471, (Part II) 613-615.
8. Delange F. The disorders induced by iodine deficiency. Thyroid 1994; 4: 107-128.
9. Boyages SC. Iodine deficiency disorders. J Clin Endocrinol Metab 1993; 77: 587-591.
10. Crews MD, Spindler SR. Thyroid hormone regulation of the transvected rat growth hormone promoter. J Biol Chem 1989; 261: 5018-5022.
11. Samuels MH, Wierman ME, Wang C, Ridgway EC. The effect of altered thyroid status on pituitary hormone messenger ribonucleic acid concentration in the rat. Endocrinology 1989; 124: 2277-2282.
12. Hochberg Z, Bick T, Harel Z. Alterations of human growth hormone binding by rat liver membranes during hypo-and hyperthyroidism. Endocrinology 1990; 126: 325-329.
13. Miell JP, Zini M, Quin JD, Jones J, Portioli I, Valcavi R. Reversible effects of cessation and recommencement of thyroxine treatment on insulin-like growth factors (IGFs) and IGF-binding proteins in patients with total thyroidectomy. J Clin Endocrinol Metab 1994; 79: 1507-1512.
14. Angerva M, Toivonen J, Leinonen P, Valimaki M, Seppala M. Thyroxine withdrawal is accompanied by decreased circulating levels of insulin-like growth factor binding protein-1 in thyroidectomized patients. J Clin Endocrinol Metab 1993; 76: 1199-1201.
15. Nanto-Salonen K, Muller HL, Hoffman AR, Vu TH, Rosenfeld RG. Mechanisms of thyroid hormone action on the insulin-like growth factor system: all thyroid hormone effects are not growth hormone mediated. Endocrinology 1993; 132: 781-788.
16. Rod E, Colzani R, Braverman LE. Adverse effects of iodine on the thyroid. The Endocrinologist 1997; 7: 245-254.
17. Chow CC, Phillips DI, Lazarus JH, Parkes AB. Effect of low dose iodide supplementation on thyroid function in potentially susceptible subjects: are dietary iodide levels in Britain acceptable? Clin Endocrinol 1991; 34: 413-416.
18. Aydin K, Bideci A, Kendirci M, Cinaz P, Kurtoǧlu S. Insulin-like growth factor-I and insulin-like growth factor binding protein-3 levels of children living in an iodine- and selenium-deficient endemic goiter area. Biol Trace Elem Res 2002; 90: 25-30.
19. Miell JP, Taylor AM, Zini M, Maheshwari HG, Ross RJ, Valcavi R. Effects of hypothyroidism and hyperthyroidism on insulin-like growth factors (IGFs) and growth hormone- and IGF-binding proteins. J Clin Endocrinol Metab 1993; 76: 950-955.
20. Kandemir N, Yordam N, Oǧuz H. Age-related differences in serum insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 levels in congenital hypothyroidism. J Pediatr Endocrinol Metab 1997; 10: 379-385.
21. Giustina A, Wehrenberg WB. Influence of thyroid hormones on the regulation of growth hormone secretion. Eur J Endocrinol 1995; 133: 646-653.
22. Seck T, Scheidt-Nave C, Ziegler R, Pfeilschifter J. Positive association between circulating free thyroxine and insulin-like growth factor I concentrations in euthyroid elderly individuals. Clin Endocr 1998; 48: 361-366.